93 related articles for article (PubMed ID: 23860499)
1. Central nervous system lymphoma newly developed 12 years after remission of an ocular adnexal lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Ohshima K; Tsuda H
Acta Haematol; 2013; 130(4):247-50. PubMed ID: 23860499
[TBL] [Abstract][Full Text] [Related]
2. Late-delayed cerebral involvement in systemic non-Hodgkin lymphoma: a second primary tumor or a tardy recurrence?
Lossos A; Ashhab Y; Sverdlin E; Amir G; Ben-Yehuda D; Siegal T
Cancer; 2004 Oct; 101(8):1843-9. PubMed ID: 15372481
[TBL] [Abstract][Full Text] [Related]
3. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
4. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma.
Shen DF; Zhuang Z; LeHoang P; Böni R; Zheng S; Nussenblatt RB; Chan CC
Ophthalmology; 1998 Sep; 105(9):1664-9. PubMed ID: 9754175
[TBL] [Abstract][Full Text] [Related]
5. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
7. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
Jahnke K; Hummel M; Korfel A; Burmeister T; Kiewe P; Klasen HA; Müller HH; Stein H; Thiel E
J Clin Oncol; 2006 Oct; 24(29):4754-7. PubMed ID: 16966685
[TBL] [Abstract][Full Text] [Related]
8. Successive B-cell lymphomas mostly reflect recurrences rather than unrelated primary lymphomas.
Geurts-Giele WR; Wolvers-Tettero IL; Dinjens WN; Lam KH; Langerak AW
Am J Clin Pathol; 2013 Jul; 140(1):114-26. PubMed ID: 23765542
[TBL] [Abstract][Full Text] [Related]
9. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
10. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
Malumbres R; Davis J; Ruiz P; Lossos IS
Br J Haematol; 2007 Sep; 138(6):749-55. PubMed ID: 17760806
[TBL] [Abstract][Full Text] [Related]
11. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
[TBL] [Abstract][Full Text] [Related]
13. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
Sugita Y; Tokunaga O; Nakashima A; Shigemori M
Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis by polymerase chain reaction of B-cell lymphoma with late relapse: a report of five cases.
Nishiuchi R; Yoshino T; Teramoto N; Sakuma I; Hayashi K; Nakamura S; Seino Y; Akagi T
Cancer; 1996 Feb; 77(4):757-62. PubMed ID: 8616769
[TBL] [Abstract][Full Text] [Related]
15. Very late central nervous system relapse in a patient with B cell lymphoblastic lymphoma.
Nagasaki A; Miyagi T; Nakazato T; Taira N; Ohshima K; Kikuchi M; Takasu N; Masauda M
Acta Haematol; 2004; 112(4):212-6. PubMed ID: 15564734
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system manifestations of marginal zone B-cell lymphoma.
Bayraktar S; Stefanovic A; Montague N; Davis J; Murray T; Lossos IS
Ann Hematol; 2010 Oct; 89(10):1003-9. PubMed ID: 20440502
[TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.
Mannami T; Yoshino T; Oshima K; Takase S; Kondo E; Ohara N; Nakagawa H; Ohtsuki H; Harada M; Akagi T
Mod Pathol; 2001 Jul; 14(7):641-9. PubMed ID: 11454995
[TBL] [Abstract][Full Text] [Related]
18. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
19. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
20. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]